Patents by Inventor Nicolas Joubert
Nicolas Joubert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240154804Abstract: The disclosure concerns a method of replacing a current key in a security element co-operating with a terminal in a network operated by a network operator, the method includes trying to decrypt the encrypted message by using the current key; selecting in a table stored in the secure element another key and try to decrypt the encrypted message by using the other key; replacing atomically the current key by the rescue key and do not use the current key anymore, the rescue key replacing the current key and, otherwise, try to decrypt the encrypted message by using another rescue key of the window if such another rescue key exists, until all rescue keys have been selected and used for decrypting the encrypted message and, if none of the rescue keys permit to decrypt the encrypted message, select the blocking key; and blocking the corresponding functionality of the security element.Type: ApplicationFiled: February 22, 2022Publication date: May 9, 2024Applicant: THALES DIS FRANCE SASInventors: Henri OHANIAN, Nicolas JOUBERT, Cyril BARRAS, Oussama BOUZAYANE
-
Patent number: 11278627Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.Type: GrantFiled: April 11, 2019Date of Patent: March 22, 2022Assignee: MC SAFInventors: Nicolas Joubert, Marie Claude Viaud-Massuard, Renaud Respaud
-
Publication number: 20190365914Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.Type: ApplicationFiled: April 11, 2019Publication date: December 5, 2019Inventors: Nicolas JOUBERT, Marie Claude VIAUD-MASSUARD, Renaud RESPAUD
-
Patent number: 10307488Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.Type: GrantFiled: July 11, 2014Date of Patent: June 4, 2019Assignee: UNIVERSITE FRANCOIS RABELAISInventors: Nicolas Joubert, Marie Claude Viaud-Massuard, Renaud Respaud
-
Patent number: 10264633Abstract: An optoelectronic circuit for receiving a variable voltage containing alternating increasing and decreasing phases. The optoelectronic circuit includes assemblies of light-emitting diodes mounted in series; a current source connected to each assembly by a switch; for each switch, a first comparison module for comparing the current passing through the switch with a current threshold; a second comparison module for comparing a voltage representing the voltage at the terminals of the current source with a voltage threshold; and a control module connected to the first and second comparison modules and designed to control the opening and closing of the switches, during each increasing phase and each decreasing phase, according to signals supplied by the first and second comparison modules.Type: GrantFiled: July 19, 2016Date of Patent: April 16, 2019Assignee: AlediaInventors: Frédéric Mercier, David Gras, Nicolas Joubert
-
Publication number: 20180227992Abstract: An optoelectronic circuit for receiving a variable voltage containing alternating increasing and decreasing phases. The optoelectronic circuit includes assemblies of light-emitting diodes mounted in series; a current source connected to each assembly by a switch; for each switch, a first comparison module for comparing the current passing through the switch with a current threshold; a second comparison module for comparing a voltage representing the voltage at the terminals of the current source with a voltage threshold; and a control module connected to the first and second comparison modules and designed to control the opening and closing of the switches, during each increasing phase and each decreasing phase, according to signals supplied by the first and second comparison modules.Type: ApplicationFiled: July 19, 2016Publication date: August 9, 2018Applicants: Aledia, Easii ICInventors: Frédéric Mercier, David Gras, Nicolas Joubert
-
Patent number: 9615244Abstract: A first device stores a subscription manager and at least two subscriptions. A first subscription is active and a second subscription is non-active. A second device sends a request for switching to the second subscription. The subscription manager sets a first variable relating to a next active subscription to the second subscription. The subscription manager sends to the first device a message requesting the first device to re-launch an execution of the subscription manager and to read data. The first device sends to the subscription manager a message including a command for re-launching an execution of the subscription manager. The subscription manager de-activates, based upon the first variable value, the first subscription. The subscription manager activates, based upon the first variable value, the second subscription, and sends to the first device operating system data relating to the second subscription, as a current active subscription.Type: GrantFiled: December 17, 2014Date of Patent: April 4, 2017Assignee: GEMALTO SAInventors: Nicolas Roussel, Nicolas Joubert, Florent Labourie, Jérôme Duprez, Frédéric Faure
-
Publication number: 20170006464Abstract: A first device stores a subscription manager and at least two subscriptions. A first subscription is active and a second subscription is non-active. A second device sends a request for switching to the second subscription. The subscription manager sets a first variable relating to a next active subscription to the second subscription. The subscription manager sends to the first device a message requesting the first device to re-launch an execution of the subscription manager and to read data. The first device sends to the subscription manager a message including a command for re-launching an execution of the subscription manager. The subscription manager de-activates, based upon the first variable value, the first subscription. The subscription manager activates, based upon the first variable value, the second subscription, and sends to the first device operating system data relating to the second subscription, as a current active subscription.Type: ApplicationFiled: December 17, 2014Publication date: January 5, 2017Applicant: GEMALTO SAInventors: Nicolas ROUSSEL, Nicolas JOUBERT, Florent LABOURIE, Jérôme DUPREZ, Frédéric FAURE
-
Publication number: 20160151515Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.Type: ApplicationFiled: July 11, 2014Publication date: June 2, 2016Inventors: Nicolas JOUBERT, Marie Claude VIAUD-MASSUARD, Renaud RESPAUD
-
Patent number: 8744406Abstract: The invention relates to a UICC comprising a toolkit applet. The UICC comprises a toolkit security component for establishing and using a secure channel for proactive commands and events exchanged by the toolkit applet of the UICC with a mobile equipment. Other communications between the UICC and the mobile equipment take place outside of this secure channel. The invention also relates to a system comprising a UICC of the above type and a mobile equipment, such as a cell phone. The invention also relates to a method to selectively protect a UICC.Type: GrantFiled: December 7, 2010Date of Patent: June 3, 2014Assignee: Gemalto SAInventors: Francois Ennesser, Nicolas Joubert, Florent Labourie, Nicolas Roussel
-
Publication number: 20120238244Abstract: (EN)The invention relates to a UICC comprising a toolkit applet. The UICC comprises a toolkit security component for establishing and using a secure channel for proactive commands and events exchanged by the toolkit applet of the UICC with a mobile equipment. Other communications between the UICC and the mobile equipment take place outside of this secure channel. The invention also relates to a system comprising a UICC of the above type and a mobile equipment, such as a cell phone. The invention also relates to a method to selectively protect a UICC.Type: ApplicationFiled: December 7, 2010Publication date: September 20, 2012Applicant: GEMALTO SAInventors: Francois Ennesser, Nicolas Joubert, Florent Labourie, Nicolas Roussel
-
Publication number: 20090004137Abstract: The invention relates to the use of an uridine derivative of formula (I); wherein —R1 represents monohalogenated alkynyl or dihalogenated alkenyl; —R2 is chosen from among hydrogen, hydroxyl, O-alkyl, O—CO alkyl and halogen; —R3 is chosen from among hydrogen, hydroxyl, O-alkyl, O—CO alkyl, halogen, SH, S-alkyl and N3; and —R4 is chosen from among hydroxyl, O-alkyl, O—CO alkyl, O-phosphate, O-diphosphate, O-triphosphate and O phosphonate, as well as its possible tautomers, its possible pharmaceutically acceptable addition salts with an acid or a base, and its N-oxide forms, for the preparation of a drug having antiviral activity against a Flaviviridae.Type: ApplicationFiled: December 22, 2005Publication date: January 1, 2009Applicants: Institute National De La Sainte Et De La Rechderche Medicale, Centre National De La Recherche SceintifiqueInventors: Vincent Aucagne, Vanessa Escuret, Fabien Zoulim, David Durantel, Christian Trepo, Luigi Agrofoglio, Nicolas Joubert, Franck Amelard